| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0003 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.00024 | 1 |